CN Patent
CN101068573A — 局部用奈帕芬胺制剂
Assigned to Novartis AG · Expires 2007-11-07 · 19y expired
What this patent protects
本发明公开了奈帕芬胺的局部用混悬液组合物。该组合物尤其适合于局部眼科施用。
USPTO Abstract
本发明公开了奈帕芬胺的局部用混悬液组合物。该组合物尤其适合于局部眼科施用。
Drugs covered by this patent
- Nevanac (NEPAFENAC) · Harrow Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.